Contemporary Pediatrician, Digital Edition, August 2012

Zelicapavir demonstrated a favorable safety profile and was well-tolerated. The N-protein inhibitor has been granted Fast Track Designation by the FDA.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Results demonstrated that those with earlier asthma onset had slower development of episodic memory.

A new study highlights how depression may drive dysmenorrhea through shared genetic pathways, emphasizing the need for mental health screening and holistic care for women.